Beleodaq (Spectrum Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the Beleodaq drug offered from Spectrum Pharmaceuticals, Inc.. This Histone Deacetylase Inhibitor [EPC],Histone Deacetylase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Spectrum Pharmaceuticals, Inc. |
NON-PROPRIETARY NAME: | Belinostat |
SUBSTANCE NAME: | BELINOSTAT |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Histone Deacetylase Inhibitor [EPC],Histone Deacetylase Inhibitors [MoA] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2014-07-21 |
END MARKETING DATE: | 0000-00-00 |
Beleodaq HUMAN PRESCRIPTION DRUG Details:
Item Description | Beleodaq from Spectrum Pharmaceuticals, Inc. |
LABELER NAME: | Spectrum Pharmaceuticals, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 500(mg/10mL) |
START MARKETING DATE: | 2014-07-21 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 68152-108_0b349468-289d-4267-bc4e-456ae16896e0 |
PRODUCT NDC: | 68152-108 |
APPLICATION NUMBER: | NDA206256 |
Other BELINOSTAT Pharmaceutical Manufacturers / Labelers: